Suzanne Hollander, MS, RD, LDN, Senior Clinical Nutrition Specialist, Boston Children's Hospital.
WATCH: Experts react to the FDA approval of sepiapterin to treat PKU
Suzanne Hollander, MS, RD, LDN; and Timothy Tramontana, MD, offer thoughts on newly FDA-approved sepiapterin for PKU.
PKU and the pediatrician with Suzanne Hollander, MS, RD, LDN
In this interview, Suzanne Hollander, MS, RD, LDN, discusses the importance of collaborative care in PKU and the impact of a new potential treatment.
PKU and sepiapterin data with Suzanne Hollander, MS, RD, LDN
A review of the clinical potential of PTC Therapeutics' sepiapterin as a novel treatment for phenylketonuria (PKU).